U-JenaValve Uqoka u-Kari Moore njengeSikhulu Esiyinhloko Sezezimali

IRVINE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. ("JenaValve noma "Inkampani"), umthuthukisi nomkhiqizi wezinhlelo ezihlukene zokushintshwa kwe-transcatheter aortic valve replacement (TAVR), namuhla umemezele ukuqokwa kwe UKari Moore njengeSikhulu Esiphezulu Sezezimali senkampani kusukela ngoMeyi 10, 2022. "Siyajabula ukwamukela u-Kari ethimbeni le-JenaValve," kusho i-CEO yakwaJenaValve uJohn Kilcoyne." UKari uneminyaka engaphezu kwengu-35 yolwazi olunzulu lwezezimali nokusebenza emshinini wezokwelapha futhi izimboni zezempilo. Ulwazi olubanzi lukaKari nobungcweti bezimboni buzosisiza ukuthi siqhubeke sisebenzisa isu lethu lomtholampilo futhi sithuthukise i-Trilogy yethu yokwelapha isifo se-aortic valve ® Imizamo Yokuthengisa Yezinhlelo Ze-Heart Valve.” UNksz Moore ujoyina u-JenaValve ngemva kokusebenza njengeSikhulu Esiphezulu Esinesibopho Sokubalwa kwe-Envista Holdings Corporation, inkampani yomhlaba wonke yemikhiqizo yamazinyo, lapho ayenomthwalo wemfanelo wokubalwa kwezimali emhlabeni wonke, ezezimali kanye nemisebenzi yezinsizakalo ezabiwe.Ngaphambi kokujoyina i-Envista Holdings Corporation, uNksz. Moore wayeyiNhloko Isikhulu Esiphendula Ngokwenzekayo se-Applied Medical Corporation, inkampani yemishini yezokwelapha yomhlaba wonke ehlinzeka ngobuchwepheshe nezisombululo zokuhlinzwa okungavamisile futhi okuvamile. UMoore waqala ukusebenza ePricewaterhouseCoopers, lapho ayesebenza khona njengozakwethu wokucwaninga amabhuku, esebenza ngokukhethekile embonini yesayensi yezempilo. Phakathi neminyaka engu-20 yomsebenzi wakhe, uNksz. Moore usekhiphe izinkampani eziningi esidlangalaleni futhi wazisiza ekuthengeni, ekuhlukaniseni nasekukhipheni izikweletu. UKari uphethe I-BA in Business Administration evela eNyuvesi yaseSouthern California futhi iyi-CPA esifundazweni saseCalifornia. “Ngijabule ngokujoyina i-JenaValve ngesikhathi esibucayi kangaka,” kusho uNksz Moore. "Ngijabule ukusebenzisana nalo lonke ithimba le-JenaValve njengoba siqhubeka sisebenzisa amasu ethu okukhula kanye nokwakha ukubaluleka ngenkathi sithuthukisa izimpilo zeziguli." Mayelana ne-JenaValve JenaValve Technology, Inc., enekomkhulu e-Irvine, eCalifornia, enezindawo ezise-Leeds, UK naseMunich, eJalimane, ithuthukisa futhi ikhiqize amasistimu we-transcatheter aortic valve replacement (TAVR) okwelapha iziguli ezine-aortic valve disease.I-JenaValve isekelwe I-Bain Capital Life Sciences and Cormorant Asset Management, kanye nabatshalizimali base-Europe nase-Asia okuhlanganisa i-Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners kanye ne-Peijia Medical Limited (HKEx: 9996) . I-United States: Ukunakwa - Izinsiza Zokucwaninga.Ikhawulelwe umthetho wenhlangano (noma wase-US) ukuze kusetshenziswe ucwaningo kuphela.